OraSure Technologies Other Long-Term Assets 2010-2024 | OSUR
OraSure Technologies other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
OraSure Technologies Annual Other Long-Term Assets (Millions of US $) |
2024 |
$2 |
2023 |
$1 |
2022 |
$1 |
2021 |
$5 |
2020 |
$2 |
2019 |
$3 |
2018 |
$4 |
2017 |
$4 |
2016 |
$2 |
2015 |
$2 |
2014 |
$1 |
2013 |
$1 |
2012 |
$0 |
2011 |
$0 |
2010 |
$1 |
2009 |
$1 |
OraSure Technologies Quarterly Other Long-Term Assets (Millions of US $) |
2024-12-31 |
$2 |
2024-09-30 |
$1 |
2024-06-30 |
$1 |
2024-03-31 |
$1 |
2023-12-31 |
$1 |
2023-09-30 |
$1 |
2023-06-30 |
$1 |
2023-03-31 |
$1 |
2022-12-31 |
$1 |
2022-09-30 |
$4 |
2022-06-30 |
$1 |
2022-03-31 |
$1 |
2021-12-31 |
$5 |
2021-09-30 |
$2 |
2021-06-30 |
$2 |
2021-03-31 |
$2 |
2020-12-31 |
$2 |
2020-09-30 |
$3 |
2020-06-30 |
$3 |
2020-03-31 |
$3 |
2019-12-31 |
$3 |
2019-09-30 |
$4 |
2019-06-30 |
$4 |
2019-03-31 |
$4 |
2018-12-31 |
$4 |
2018-09-30 |
$5 |
2018-06-30 |
$5 |
2018-03-31 |
$4 |
2017-12-31 |
$4 |
2017-09-30 |
$4 |
2017-06-30 |
$4 |
2017-03-31 |
$3 |
2016-12-31 |
$2 |
2016-09-30 |
$2 |
2016-06-30 |
$2 |
2016-03-31 |
$2 |
2015-12-31 |
$2 |
2015-09-30 |
$2 |
2015-06-30 |
$2 |
2015-03-31 |
$1 |
2014-12-31 |
$1 |
2014-09-30 |
$1 |
2014-06-30 |
$1 |
2014-03-31 |
$1 |
2013-12-31 |
$1 |
2013-09-30 |
$1 |
2013-06-30 |
$0 |
2013-03-31 |
$0 |
2012-12-31 |
$0 |
2012-09-30 |
$0 |
2012-06-30 |
$0 |
2012-03-31 |
$0 |
2011-12-31 |
$0 |
2011-09-30 |
$0 |
2011-06-30 |
$0 |
2011-03-31 |
$0 |
2010-12-31 |
$1 |
2010-09-30 |
$1 |
2010-06-30 |
$1 |
2010-03-31 |
$1 |
2009-12-31 |
$1 |
2009-09-30 |
$0 |
2009-06-30 |
$0 |
2009-03-31 |
$0 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED PRODUCTS |
$0.228B |
$0.186B |
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.
|